Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 …

W Chen, Y Zhao, X Xie, J Liu, J Li, C Zhao, S Wang… - Vaccine, 2019 - Elsevier
Background A quadrivalent human papillomavirus (qHPV) vaccine (HPV6/11/16/18) has
demonstrated efficacy and acceptable safety in international studies. However, these studies …
被引用次数：31 相关文章

Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 …

W Chen, Y Zhao, X Xie, J Liu, J Li, C Zhao, S Wang… - Vaccine, 2019 - europepmc.org
Background A quadrivalent human papillomavirus (qHPV) vaccine (HPV6/11/16/18) has
demonstrated efficacy and acceptable safety in international studies. However, these studies …

Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 …

W Chen, Y Zhao, X Xie, J Liu, J Li, C Zhao… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Background A quadrivalent human papillomavirus (qHPV) vaccine (HPV6/11/16/18) has
demonstrated efficacy and acceptable safety in international studies. However, these studies …

Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 …

CW Chen Wen, ZY Zhao Yun, XX Xie Xing… - 2019 - cabidigitallibrary.org
Background: A quadrivalent human papillomavirus (qHPV) vaccine (HPV6/11/16/18) has
demonstrated efficacy and acceptable safety in international studies. However, these studies …

[引用][C] Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during …

W Chen, Y Zhao, X Xie, J Liu, J Li, C Zhao, S Wang… - 2019